Please ensure Javascript is enabled for purposes of website accessibility

Leukogene Therapeutics

SC Launch Inc. has invested in Charleston-based Leukogene Therapeutics, supporting its targeted immunotherapies and FDA-designated treatment for acute myeloid leukemia. (Photo/Leukogene Therapeutics)
Nov 18, 2025

SC Launch invests in Charleston biotech advancing cancer therapy

SC Launch Inc. has invested in Charleston-based Leukogene Therapeutics, supporting its targeted immunotherapies and FDA-designated treatment for acute myeloid leukemia.